|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 21 studies with search of: | Mesilato de delavirdina OR Rescriptor[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
|
||||
| 2 | Completed |
A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies
|
||||
| 3 | Completed |
Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
|
||||
| 4 | Completed |
Safety And Efficacy Of Rescriptor In Patients For HIV Patients
|
||||
| 5 | Completed |
A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
|
||||
| 6 | Terminated |
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
|
||||
| 7 | Completed |
A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
|
||||
| 8 | Completed |
A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
|
||||
| 9 | Completed |
A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
|
||||
| 10 | Completed |
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
|
||||
| 11 | Completed |
Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
|
||||
| 12 | Terminated |
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
|
||||
| 13 | Completed |
A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
|
||||
| 14 | Completed |
Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
|
||||
| 15 | Completed |
The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
|
||||
| 16 | Terminated |
Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
|
||||
| 17 | Completed |
A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
|
||||
| 18 | Completed |
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
|
||||
| 19 | Completed |
Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
|
||||
| 20 | Recruiting |
Clinical Trial of CNS-targeted HAART (CIT2)
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-21) |
|